Ameriprise Financial Inc Savara Inc Transaction History
Ameriprise Financial Inc
- $375 Billion
- Q4 2024
A detailed history of Ameriprise Financial Inc transactions in Savara Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 12,139 shares of SVRA stock, worth $34,231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,139Holding current value
$34,231% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding SVRA
# of Institutions
138Shares Held
152MCall Options Held
60.6KPut Options Held
12.3K-
Nea Management Company, LLC Timonium, MD24.5MShares$69 Million5.37% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$41.1 Million12.07% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$34.9 Million6.2% of portfolio
-
Vestal Point Capital, LP New York, NY10.8MShares$30.4 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.31MShares$23.4 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $322M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.